Latest News and Press Releases
Want to stay updated on the latest news?
-
FORM 8.5 (EPT/RI) Amendment PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the...
-
Heritage Distilling ($CASK) will change its ticker symbol on the Nasdaq to IPST to reflect the Company’s strategic focus on its $IP token treasury strategy
-
Acquisition of leading cannabis company marks major milestone in InterCure’s commercial expansion strategy, bringing access to premium American brands and state-of-the-art cultivation technologies ...
-
La Quinta, CA and Durham, NC, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Sun World International and Pairwise today announced the formation of a joint venture to collaborate in specialty fruit, beginning...
-
Austin, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Fetal Bovine Serum Market Size & Growth Outlook: According to S&S Insider, the Fetal Bovine Serum Market size was valued at USD 2.12 billion in...
-
New York, Sept. 19, 2025 (GLOBE NEWSWIRE) -- The global pharmaceutical temperature-controlled packaging solutions market size is estimated to be worth USD 11.50 billion by 2034, increasing from USD...
-
GAITHERSBURG, Md., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured new purchase orders from an international government partner for a...
-
Pending the European Commission’s final decision, nipocalimab could be the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK...
-
MONACO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Speeding up the environmental transition and building sustainable, connected, people-centred marina infrastructure. Investors, architects, marina...
-
REDWOOD CITY, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a clinical-stage biotechnology company focused on development of briquilimab, a novel...